APA (7th ed.) Citation

GI, M., R, H., MDP, R., DA, O., A, L., M, Q., . . . C, C. (2026). The antitumor activity of bismuth lipophilic nanoparticles (BisBAL NPs) on human glioblastoma is higher than temozolomide. Bio-medical materials and engineering, 37(2), 105. https://doi.org/10.1177/09592989251414231

Chicago Style (17th ed.) Citation

GI, Martinez-Gonzalez, et al. "The Antitumor Activity of Bismuth Lipophilic Nanoparticles (BisBAL NPs) on Human Glioblastoma Is Higher than Temozolomide." Bio-medical Materials and Engineering 37, no. 2 (2026): 105. https://doi.org/10.1177/09592989251414231.

MLA (9th ed.) Citation

GI, Martinez-Gonzalez, et al. "The Antitumor Activity of Bismuth Lipophilic Nanoparticles (BisBAL NPs) on Human Glioblastoma Is Higher than Temozolomide." Bio-medical Materials and Engineering, vol. 37, no. 2, 2026, p. 105, https://doi.org/10.1177/09592989251414231.